Cannamore Biotechs
Cannabis-based Treatment Solutions
StartupCannamore Biotechs is a Bnei Brak-based startup in the Health Tech & Life Sciences sector, established in 2018. Cannabis-based Treatment Solutions. Cannamore Biotechs was founded by David Bassa. The company has 1-10 employees. Core technologies: Biologicals, Herbals.
The company follows a B2B business model. Product stage: Clinical Trial.
- StagePre-Funding
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQBnei Brak
- DistrictCenter District
- Last RoundUndisclosed
David BassaCEO
1 article covered by sources including www.healtheuropa.com.
What does Cannamore Biotechs do?
CannaMore is a preclinical- and clinical-stage research platform company committed to the development of novel and improved cannabis-based treatment options that will potentially benefit millions of patients worldwide. The company is focusing on the development of a CBD-based solution for the treatment of bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases. CannaMore is a portfolio company of BioSeedXL.
Who founded Cannamore Biotechs?
Cannamore Biotechs was founded in 2018 by David Bassa (CEO).
What sector is Cannamore Biotechs in?
Cannamore Biotechs operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, Drugs Discovery & Development, with core technologies in Biologicals, Herbals. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology, Pharmaceuticals, Healthcare, Laboratories.
Where is Cannamore Biotechs located?
Cannamore Biotechs is based in Barukh Hirsch St 18, Bnei Brak, Israel, Center District.